| Name | Title | Contact Details |
|---|---|---|
Naomi Moray |
Head of Learning | Profile |
Kevin McGann |
Vice President Finance | Profile |
Robert Copeland |
President and Co Founder | Profile |
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Employing a proprietary Fast-Clear linker technology, Fusion connects alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha emitting payloads to tumors. Fusion`s lead program, FPI-1434, is currently in a Phase 1 clinical trial. Fusion is headquartered in Hamilton, ON, with offices in Boston, MA.
GenVault Corporation is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient`s lymph nodes to be used as bioreactors to regrow functioning ectopic organs.
Temporary Technical Services Inc is a Jackson, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts (USA).